Results 41 to 50 of about 487,050 (179)

VERITAS: Harnessing the power of nomenclature in biologic discovery

open access: yesmAbs, 2023
We are entering an era in which therapeutic proteins are assembled using building block-like strategies, with no standardized schema to discuss these formats. Existing nomenclatures, like AbML, sacrifice human readability for precision.
Riti Biswas   +6 more
doaj   +1 more source

Development of antibodies for life-detection experiment in extreme environments; implications for astrobiology [PDF]

open access: yes, 2010
The Life Marker Chip (LMC) instrument is an antibody assay-based system which will attempt to detect molecular signatures of Life in the Martian subsurface as part of the payload on board the European Space Agency (ESA) ExoMars mission rover, currently
Derveni, Maria Elisavet
core   +7 more sources

Engineering multi-specific antibodies against HIV-1

open access: yesRetrovirology, 2018
As increasing numbers of broadly neutralizing monoclonal antibodies (mAbs) against HIV-1 enter clinical trials, it is becoming evident that combinations of mAbs are necessary to block infection by the diverse array of globally circulating HIV-1 strains ...
Neal N. Padte   +3 more
doaj   +1 more source

Generation of a symmetrical trispecific NK cell engager based on a two-in-one antibody

open access: yesFrontiers in Immunology, 2023
To construct a trispecific IgG-like antibody at least three different binding moieties need to be combined, which results in a complex architecture and challenging production of these molecules.
Julia Harwardt   +9 more
doaj   +1 more source

Human monoclonal antibodies and monoclonal antibody multispecificity [PDF]

open access: yesBritish Journal of Cancer, 1987
The majority of human anti-tumour monoclonal antibodies (Mabs) isolated to date have been disappointing. Firstly, they react or cross react with intracellular cytoskeletal proteins or nuclear antigens and therefore are of limited value as blood borne agents.
A M, Campbell, P, Whitford, R E, Leake
openaire   +2 more sources

Acknowledgment to Reviewers of Antibodies in 2020

open access: yes, 2021
Peer review is the driving force of journal development, and reviewers are gatekeepers who ensure that Antibodies maintains its standards for the high quality of its published papers [...
Antibodies Editorial Office
core   +1 more source

Acknowledgement to Reviewers of Antibodies in 2018

open access: yes, 2019
Peer review is an essential part of the publication process, ensuring that Antibodies maintains high quality standards for its published papers.
Antibodies Editorial Office Antibodies Editorial Office
core   +2 more sources

Generation of Multispecific Antibodies with Immune Cell Modulating Functions [PDF]

open access: yes, 2023
Within the field of biologics, monoclonal antibodies have ruled the market with blockbuster and top selling drugs over the last decades. With the advancements in technological discoveries, lightspeed progress has been achieved to discover novel ...
Carrara, Stefania C.
core   +1 more source

Efficient and inexpensive transient expression of multispecific multivalent antibodies in Expi293 cells [PDF]

open access: yes, 2017
Background: Immunotherapy is a very fast expanding field within drug discovery and, hence, rapid and inexpensive expression of antibodies would be extremely valuable. Antibodies are, however, difficult to express.
Hultqvist, Greta   +14 more
core   +1 more source

CD36‐mediated lipid rewiring in the metabolic adaptation of tumour ecosystems

open access: yesThe FEBS Journal, EarlyView.
Nutrient deprivation drives a lipid‐centric shift in tumour metabolic symbiosis and signalling network. CD36 functions as a bidirectional bridge, transferring fatty acids from stromal donors (adipocytes, CAFs) to the ecosystem tumour‐ and microenvironment‐dependently.
Anna Sebestyén   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy